(Cesa) and Cellulose Synthase-Like (Csl) Proteins
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Enzyme Phosphatidylserine Synthase (Saccharomyces Cerevisae/Chol Gene/Transformation) V
Proc. Nati. Acad. Sci. USA Vol. 80, pp. 7279-7283, December 1983 Genetics Isolation of the yeast structural gene for the membrane-associated enzyme phosphatidylserine synthase (Saccharomyces cerevisae/CHOl gene/transformation) V. A. LETTS*, L. S. KLIG*, M. BAE-LEEt, G. M. CARMANt, AND S. A. HENRY* *Departments of Genetics and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY 10461; and tDepartment of Food Science, Cook College, New Jersey Agricultural Experimental Station, Rutgers University, New Brunswick, NJ 08903 Communicated by Frank Lilly, August 11, 1983 ABSTRACT The structural gene (CHOI) for phosphatidyl- Mammals, for example, synthesize PtdSer by an exchange re- serine synthase (CDPdiacylglycerol:L-serine O-phosphatidyl- action with PtdEtn (9). However, PtdSer synthase is found in transferase, EC 2.7.8.8) was isolated by genetic complementation E. coli and indeed the structural gene for the E. coli enzyme has in Saccharomyces cerevmae from a bank of yeast genomic DNA been cloned (10). Thus, cloning of the structural gene for the on a chimeric plasmid. The cloned DNA (4.0 kilobases long) was yeast enzyme will permit a detailed comparison of the structure shown to represent a unique sequence in the yeast genome. The and function of prokaryotic and eukaryotic genes and gene DNA sequence on an integrative plasmid was shown to recombine products. The availability of a clone of the CHOI gene will per- into the CHOi locus, confwrming its genetic identity. The chol yeast mit analysis of its regulation at the transcriptional level. Fur- strain transformed with this gene on an autonomously replicating thermore, the cloning of the CHOI gene provides us with the plasmid had significantly increased activity of the regulated mem- the levels of PtdSer synthase in the cell, brane-associated enzyme phosphatidylserine synthase. -
Assembly of the Membrane Domain of ATP Synthase in Human Mitochondria
Assembly of the membrane domain of ATP synthase in human mitochondria Jiuya Hea,1, Holly C. Forda,1, Joe Carrolla, Corsten Douglasa, Evvia Gonzalesa, Shujing Dinga, Ian M. Fearnleya, and John E. Walkera,2 aMedical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0XY, United Kingdom Contributed by John E. Walker, January 16, 2018 (sent for review December 20, 2017; reviewed by Ulrich Brandt and Nikolaus Pfanner) The ATP synthase in human mitochondria is a membrane-bound mitochondria in human ρ0 cells lack organellar DNA and contain assembly of 29 proteins of 18 kinds. All but two membrane another incomplete ATP synthase, necessarily with no ATP6 or components are encoded in nuclear genes, synthesized on cyto- ATP8 (7, 9). These incomplete vestigial ATP synthases provide plasmic ribosomes, and imported into the matrix of the organelle, insight into the pathway of assembly of the complete enzyme. where they are assembled into the complex with ATP6 and ATP8, Here we investigated the effects of the selective removal of su- the products of overlapping genes in mitochondrial DNA. Disrup- pernumerary membrane subunits e, f, g, DAPIT, and 6.8PL on tion of individual human genes for the nuclear-encoded subunits assembly of human ATP synthase. in the membrane portion of the enzyme leads to the formation of intermediate vestigial ATPase complexes that provide a descrip- Results tion of the pathway of assembly of the membrane domain. The Human Cells Lacking Supernumerary Subunits. The human genes key intermediate complex consists of the F1-c8 complex inhibited ATP5I, ATP5J2, ATP5L, USMG5, and C14orf2 (SI Appendix, Fig. -
Comparative Analysis of High-Throughput Assays of Family-1 Plant Glycosyltransferases
International Journal of Molecular Sciences Article Comparative Analysis of High-Throughput Assays of Family-1 Plant Glycosyltransferases Kate McGraphery and Wilfried Schwab * Biotechnology of Natural Products, Technische Universität München, 85354 Freising, Germany; [email protected] * Correspondence: [email protected]; Tel.: +49-8161-712-912; Fax: +49-8161-712-950 Received: 27 January 2020; Accepted: 21 March 2020; Published: 23 March 2020 Abstract: The ability of glycosyltransferases (GTs) to reduce volatility, increase solubility, and thus alter the bioavailability of small molecules through glycosylation has attracted immense attention in pharmaceutical, nutraceutical, and cosmeceutical industries. The lack of GTs known and the scarcity of high-throughput (HTP) available methods, hinders the extrapolation of further novel applications. In this study, the applicability of new GT-assays suitable for HTP screening was tested and compared with regard to harmlessness, robustness, cost-effectiveness and reproducibility. The UDP-Glo GT-assay, Phosphate GT Activity assay, pH-sensitive GT-assay, and UDP2-TR-FRET assay were applied and tailored to plant UDP GTs (UGTs). Vitis vinifera (UGT72B27) GT was subjected to glycosylation reaction with various phenolics. Substrate screening and kinetic parameters were evaluated. The pH-sensitive assay and the UDP2-TR-FRET assay were incomparable and unsuitable for HTP plant GT-1 family UGT screening. Furthermore, the UDP-Glo GT-assay and the Phosphate GT Activity assay yielded closely similar and reproducible KM, vmax, and kcat values. Therefore, with the easy experimental set-up and rapid readout, the two assays are suitable for HTP screening and quantitative kinetic analysis of plant UGTs. This research sheds light on new and emerging HTP assays, which will allow for analysis of novel family-1 plant GTs and will uncover further applications. -
Citrate Synthase a Mitochondrial Marker Enzyme
Oroboros Protocols Enzymes Mitochondrial Physiology Network 17.04(04):1-12 (2020) Version 04: 2020-04-18 ©2013-2020 Oroboros Updates: http://wiki.oroboros.at/index.php/MiPNet17.04_CitrateSynthase Laboratory Protocol: Citrate synthase a mitochondrial marker enzyme Eigentler A1,2, Draxl A2, Gnaiger E1,2 1D. Swarovski Research Laboratory Dept Visceral, Transplant and Thoracic Surgery Medical Univ Innsbruck, Austria www.mitofit.org 2Oroboros Instruments High-Resolution Respirometry Schöpfstrasse 18, A-6020 Innsbruck, Austria Email: [email protected]; www.oroboros.at 1. Background 1 1.1. Enzymatic reaction catalyzed by citrate synthase 2 1.2. Principle of spectrophotometric enzyme assay 2 1.3. Temperature of enzyme assay 3 2. Reagents and buffers 3 2.1. Prepare every month new and store at 4 °C 3 2.2. Prepare 12.2 mM acetyl-CoA, store at -20 °C 3 2.3. Prepare fresh every day 3 2.4. Chemicals 4 3. Sample preparation 4 4. Measurement: Spectrophotometer HP8452A Diode Array 6 4.1. Measurement of CS activity in 1 mL cuvette 6 4.2. Blank measurement 6 4.3. Sample measurement 7 4.4. Experimental procedure 7 5. Data analysis: calculation of specific CS activity 8 5.1. Absorbance, concentration and rate of reaction 8 5.2. Specific enzyme activity: reaction rate per unit sample 8 6. Normalization of respiratory flux for CS activity 9 6.1. Flow per instrumental chamber, IO2 9 6.2. Flux per chamber volume, JV,O2 10 6.3. Flow per experimental object, IO2/N 10 6.4. Flux per sample mass, JO2/m 10 7. References 10 8. -
Supplementary Information
Supplementary information (a) (b) Figure S1. Resistant (a) and sensitive (b) gene scores plotted against subsystems involved in cell regulation. The small circles represent the individual hits and the large circles represent the mean of each subsystem. Each individual score signifies the mean of 12 trials – three biological and four technical. The p-value was calculated as a two-tailed t-test and significance was determined using the Benjamini-Hochberg procedure; false discovery rate was selected to be 0.1. Plots constructed using Pathway Tools, Omics Dashboard. Figure S2. Connectivity map displaying the predicted functional associations between the silver-resistant gene hits; disconnected gene hits not shown. The thicknesses of the lines indicate the degree of confidence prediction for the given interaction, based on fusion, co-occurrence, experimental and co-expression data. Figure produced using STRING (version 10.5) and a medium confidence score (approximate probability) of 0.4. Figure S3. Connectivity map displaying the predicted functional associations between the silver-sensitive gene hits; disconnected gene hits not shown. The thicknesses of the lines indicate the degree of confidence prediction for the given interaction, based on fusion, co-occurrence, experimental and co-expression data. Figure produced using STRING (version 10.5) and a medium confidence score (approximate probability) of 0.4. Figure S4. Metabolic overview of the pathways in Escherichia coli. The pathways involved in silver-resistance are coloured according to respective normalized score. Each individual score represents the mean of 12 trials – three biological and four technical. Amino acid – upward pointing triangle, carbohydrate – square, proteins – diamond, purines – vertical ellipse, cofactor – downward pointing triangle, tRNA – tee, and other – circle. -
Understanding Carbamoyl-Phosphate Synthetase I (CPS1) Deficiency by Using Expression Studies and Structure-Based Analysis
Understanding carbamoyl-phosphate synthetase I (CPS1) deficiency by using expression studies and structure-based analysis. Satu Pekkala, Ana Isabel Martínez, Belén Barcelona, Igor Yefimenko, Ulrich Finckh, Vicente Rubio, Javier Cervera To cite this version: Satu Pekkala, Ana Isabel Martínez, Belén Barcelona, Igor Yefimenko, Ulrich Finckh, et al.. Un- derstanding carbamoyl-phosphate synthetase I (CPS1) deficiency by using expression studies and structure-based analysis.. Human Mutation, Wiley, 2010, 31 (7), pp.801. 10.1002/humu.21272. hal-00552391 HAL Id: hal-00552391 https://hal.archives-ouvertes.fr/hal-00552391 Submitted on 6 Jan 2011 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Human Mutation Understanding carbamoyl-phosphate synthetase I (CPS1) deficiency by using expression studies and structure-based analysis. For Peer Review Journal: Human Mutation Manuscript ID: humu-2009-0569.R1 Wiley - Manuscript type: Research Article Date Submitted by the 17-Mar-2010 Author: Complete List of Authors: Pekkala, Satu; Centro de Investigación Príncipe Felipe, Molecular Recognition Martínez, Ana; Centro de Investigación Príncipe Felipe, Molecular Recognition Barcelona, Belén; Centro de Investigación Príncipe Felipe, Molecular Recognition Yefimenko, Igor; Instituto de Biomedicina de Valencia (IBV-CSIC) Finckh, Ulrich; MVZ Dortmund Dr. -
Release of Glycosyltransferase and Glycosidase Activities from Normal and Transformed Cell Lines1
[CANCER RESEARCH 41, 2611-2615, July 1981J 0008-5472/81 /0041-OOOOS02.00 Release of Glycosyltransferase and Glycosidase Activities from Normal and Transformed Cell Lines1 Wayne D. Klohs,2 Ralph Mastrangelo, and Milton M. Weiser Division of Gastroenterology and Nutrition, Department of Medicine, State University of New York at Buffalo, Buffalo, New York 14215 ABSTRACT Indeed, a cancer-associated isoenzyme of serum galactosyl transferase has been reported in humans and animals with The release of galactosyltransferase, sialyltransferase, and certain malignant cancers (24, 26). Bernacki and Kim (2) and several glycosidase activities into the growth media from sev Weiser and Podolsky (34) have suggested that such increases eral normal and transformed cell lines was examined. Six of in serum glycosyltransferase levels may be the consequence the seven cell lines released galactosyltransferase into their of both an increased production and release from the tumor culture media. Only the human leukemia CCRF-CEM cells cells, perhaps through cell surface shedding of the enzymes, failed to release demonstrable galactosyltransferase activity. but the validity of this supposition has yet to be demonstrated. Release of galactosyltransferase activity into the media closely It is also not clear whether the elevated levels of circulating paralleled the growth curves for all but the BHKpy cells. These glycosyltransferases perform any molecular or physiological cells continued to release peak levels of galactosyltransferase function relative to the malignant -
Prospects for New Antibiotics: a Molecule-Centered Perspective
The Journal of Antibiotics (2014) 67, 7–22 & 2014 Japan Antibiotics Research Association All rights reserved 0021-8820/14 www.nature.com/ja REVIEW ARTICLE Prospects for new antibiotics: a molecule-centered perspective Christopher T Walsh and Timothy A Wencewicz There is a continuous need for iterative cycles of antibiotic discovery and development to deal with the selection of resistant pathogens that emerge as therapeutic application of an antibiotic becomes widespread. A short golden age of antibiotic discovery from nature followed by a subsequent golden half century of medicinal chemistry optimization of existing molecular scaffolds emphasizes the need for new antibiotic molecular frameworks. We bring a molecule-centered perspective to the questions of where will new scaffolds come from, when will chemogenetic approaches yield useful new antibiotics and what existing bacterial targets merit contemporary re-examination. The Journal of Antibiotics (2014) 67, 7–22; doi:10.1038/ja.2013.49; published online 12 June 2013 Keywords: antibiotics; mechanism of action; natural products; resistance A PERSONAL PATHWAY TO ANTIBIOTICS RESEARCH chemical logic and molecular machinery and, in part, with the hope For one of us (CTW), a career-long interest in antibiotics1 was that one might learn to reprogram natural antibiotic assembly lines to spurred by discussions on the mechanism of action of engineer improved molecular variants. D-fluoroalanine2,3 during a seminar visit, as a second year assistant We have subsequently deciphered many of the rules -
Polyketide Synthesis in Vitro on a Modular Polyketide Synthase
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Polyketide synthesis in vitro on a modular polyketide synthase Kirsten EH Wiesmannl, Jesus Cortkl, Murray JB Brown*, Annabel 1 Cutter*, James Staunton*, and Peter F Leadlay’* ‘Cambridge Centre for Molecular Recognition and Department of Biochemistry, University of Cambridge, Cambridge CB2 IQW, UK, Xambridge Centre for Molecular Recognition and Department of Organic Chemistry, University of Cambridge, Cambridge CB2 1 EW, UK Background: The 6-deoxyerythronolide B synthase out to purify the chimaeric enzyme and to determine its (DEBS) of Sacckavopolyspora erytkraea, which synthesizes activity in vitro. the aglycone core of the antibiotic erythromycin A, con- Results: The purified DEBSl-TE multienzyme catalyzes tains some 30 active sites distributed between three mul- synthesis of triketide lactones in vitro.The synthase specif- tienzyme polypeptides (designated DEBSl-3). This ically uses the (25’)-isomer of methylmalonyl-CoA, as complexity has hitherto frustrated mechanistic analysis of previously proposed, but has a more relaxed specificity for such enzymes. We previously produced a mutant strain of the starter unit than in vivo. S. erytkraea in which the chain-terminating cyclase Conclusions: We have obtained a purified polyketide domain (TE) is fused to the carboxyl-terminus of synthase system, derived from DEBS, which retains cat- DEBSl, the multienzyme that catalyzes the first two alytic activity. This approach opens the way for mechanis- rounds of polyketide chain extension in S. erytkraea. This tic and structural analyses of active multienzymes derived mutant strain produces triketide lactone in vivo. We set from any modular polyketide synthase. -
Nucleotide Sugars in Chemistry and Biology
molecules Review Nucleotide Sugars in Chemistry and Biology Satu Mikkola Department of Chemistry, University of Turku, 20014 Turku, Finland; satu.mikkola@utu.fi Academic Editor: David R. W. Hodgson Received: 15 November 2020; Accepted: 4 December 2020; Published: 6 December 2020 Abstract: Nucleotide sugars have essential roles in every living creature. They are the building blocks of the biosynthesis of carbohydrates and their conjugates. They are involved in processes that are targets for drug development, and their analogs are potential inhibitors of these processes. Drug development requires efficient methods for the synthesis of oligosaccharides and nucleotide sugar building blocks as well as of modified structures as potential inhibitors. It requires also understanding the details of biological and chemical processes as well as the reactivity and reactions under different conditions. This article addresses all these issues by giving a broad overview on nucleotide sugars in biological and chemical reactions. As the background for the topic, glycosylation reactions in mammalian and bacterial cells are briefly discussed. In the following sections, structures and biosynthetic routes for nucleotide sugars, as well as the mechanisms of action of nucleotide sugar-utilizing enzymes, are discussed. Chemical topics include the reactivity and chemical synthesis methods. Finally, the enzymatic in vitro synthesis of nucleotide sugars and the utilization of enzyme cascades in the synthesis of nucleotide sugars and oligosaccharides are briefly discussed. Keywords: nucleotide sugar; glycosylation; glycoconjugate; mechanism; reactivity; synthesis; chemoenzymatic synthesis 1. Introduction Nucleotide sugars consist of a monosaccharide and a nucleoside mono- or diphosphate moiety. The term often refers specifically to structures where the nucleotide is attached to the anomeric carbon of the sugar component. -
An Assay Method for Glycogen Debranching Enzyme Using New Fluorogenic Substrates and Its Application to Detection of the Enzyme in Mouse Brain
J. Biochem. 123, 932-936 (1998) An Assay Method for Glycogen Debranching Enzyme Using New Fluorogenic Substrates and Its Application to Detection of the Enzyme in Mouse Brain Kaoru Omichi1 and Sumihiro Hase Department of Chemistry, Graduate School of Science, Osaka University, Toyonaka, Osaka 560-0043 Received for publication, December 11, 1997 An assay method for glycogen debranching enzyme involving fluorogenic dextrins as substrates was developed. Two dextrins were prepared from 6-0-ƒ¿-D-glucosyl-ƒ¿-cyclo dextrin and glucose by taking advantage of the action of Bacillus macerans cyclodextrin glucanotransferase, and converted by pyridylamination to fluorogenic derivatives. Struc tural analysis of the fluorogenic dextrins by FAB-MS, partial acid hydrolysis, and gluco amylase digestion revealed that they were Glcƒ¿l-4(Glcƒ¿l-6)Glcƒ¿l-4Glcƒ¿l-4Glcƒ¿l-4Glc- PA (FD6) and Glcƒ¿l-4Glcƒ¿l-4(Glcƒ¿l-6)Glcƒ¿l-4Glcƒ¿l-4Glcƒ¿l-4Glc-PA (FD7). Using the glycogen debranching enzyme from rabbit muscle, FD6 and FD7 were, respectively, hydrolyzed to PA-maltopentaose and PA-maltohexaose, in addition to glucose, showing that these two fluorogenic dextrins are suitable substrates for assaying the glycogen debranching enzyme. An assay method involving the separation and quantification by HPLC of the characteristic fluorogenic products was successfully applied to determination of the distribution of the enzyme activity in mouse cerebrum. Key words: assay methods, fluorogenic substrate, glycogen debranching enzyme, HPLC. Glycogen debranching enzyme is known to be involved in enzymes such as a-amylase [EC 3.2.1.1] and ƒ¿-gluco- the degradation of glycogen into glucose-1-phosphate and sidase [EC 3.2.1.20]. -
Generate Metabolic Map Poster
Authors: Pallavi Subhraveti Peter D Karp Ingrid Keseler An online version of this diagram is available at BioCyc.org. Biosynthetic pathways are positioned in the left of the cytoplasm, degradative pathways on the right, and reactions not assigned to any pathway are in the far right of the cytoplasm. Transporters and membrane proteins are shown on the membrane. Anamika Kothari Periplasmic (where appropriate) and extracellular reactions and proteins may also be shown. Pathways are colored according to their cellular function. Gcf_000980815Cyc: Corynebacterium camporealensis DSM 44610 Cellular Overview Connections between pathways are omitted for legibility. Ron Caspi phosphate phosphate (S)-lactate phosphate ammonium predicted ABC RS04760 RS02955 RS06425 RS10630 transporter of phosphate phosphate (S)-lactate phosphate ammonium phosphate Amine and Tetrapyrrole Biosynthesis Amino Acid Degradation glutaminyl-tRNA gln Aminoacyl-tRNA Charging Polyamine a ring-opened 7- a DNA containing (1S,2R)-1- a [ThiI sulfur- biosynthesis via transamidation Biosynthesis an apo [peptidyl- all-trans- an L-asparaginyl- an L-cysteinyl- Polyprenyl Biosynthesis siroheme biosynthesis TCA cycle TCA cycle IV (2-oxoglutarate decarboxylase) L-valine degradation I L-asparagine methylguanine coenzyme A an apurinic/ ser C-(indol-3- carrier protein]- cys a [glutamine- L-isoleucine degradation I L-leucine degradation I L-threonine carrier protein] ATP retinyl palmitate [tRNA Asn ] [tRNA Cys ] dGDP spermidine degradation I in DNA apyrimidinic site yl)glycerol L-cysteine synthetase]-